Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00042679
Status:
COMPLETED
Last Update Posted:
2006-07-19
First Post:
2002-08-02
Brief Title:
A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha LY900003 ISIS 3521 Plus Gemcitabine and Carboplatin in Patients With Advanced Previously Untreated Non-Small Cell Lung Cancer
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-06
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2002-08-02
First Submit QC Date:
August 5 2002
Study First Post Date:
2002-08-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2006-07-18
Last Update Post Date:
2006-07-19
Last Update Post Date Type:
ESTIMATED